Anzeige
Meldung des Tages: Quanten-Computer: Unglaubliche Bewertungen – unglaubliche Chancen!

Grail News

Aktie
WKN:  A40F8M ISIN:  US3847471014 US-Symbol:  GRAL Land:  USA
50,29 $
-1,52 $
-2,93%
43,290 € 06.03.26
Depot/Watchlist
Marktkapitalisierung *
2,80 Mrd. €
Streubesitz
24,25%
KGV
-9,73
Index-Zuordnung
-

Grail News

04.03.26 - PR Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire
02.03.26 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
24.02.26 - PR Newswire
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference PR Newswire
24.02.26 - PR Newswire
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm ...
19.02.26 - PR Newswire
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
19.02.26 - PR Newswire
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
Landmark NHS-​Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher ...
16.02.26 - PR Newswire
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results PR Newswire
29.01.26 - PR Newswire
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-​Cancer Early Detection Test PR Newswire
15.12.25 - PR Newswire
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.12.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.11.25 - PR Newswire
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference PR Newswire
12.11.25 - PR Newswire
GRAIL Reports Third Quarter 2025 Financial Results
GRAIL Reports Third Quarter 2025 Financial Results PR Newswire
04.11.25 - PR Newswire
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference PR Newswire
29.10.25 - PR Newswire
GRAIL to Announce Third Quarter 2025 Financial Results
GRAIL to Announce Third Quarter 2025 Financial Results PR Newswire
20.10.25 - PR Newswire
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
GRAIL, Inc. Announces $325.0 Million Private Placement Financing PR Newswire
20.10.25 - PR Newswire
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-​Cancer Early Detection Test in Symptomatic Individuals at the ...
17.10.25 - PR Newswire
/U P D A T E -- GRAIL, Inc./
/U P D A T E -- GRAIL, Inc./ PR Newswire
17.10.25 - PR Newswire
Precision Oncology Approaches Drive $312B Market Transformation
Precision Oncology Approaches Drive $312B Market Transformation PR Newswire
17.10.25 - PR Newswire
Precision Oncology Approaches Drive $312B Market Transformation
Precision Oncology Approaches Drive $312B Market Transformation PR Newswire
16.10.25 - PR Newswire
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-​Cancer Early Detection Test to Asia PR Newswire

Newssuche

Videos

newspaper
04.03.26 +13,81%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »